Back
Day Range
$60.83
$63.47
52-Week Range
$29.31
$70.98
Volume
1,357,301
50D / 200D Avg
$63.71
/
$53.26
Prev Close
$61.70
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.6 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -891.6 | 3.9 |
| Rev Growth 5Y % | 5.7 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue grew 5.74% annually over 5 years — modest growth
Negative free cash flow of -534.82M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 370.82%
Growth
Revenue Growth (5Y)
5.74%
Revenue (1Y)376.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-73.52%
Net Margin-891.60%
Op. Margin-695.44%
Safety
Debt / Equity
N/A
Current Ratio4.53
Interest Coverage-5.89
Valuation
P/E Ratio
-9.56
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 376.56% | Revenue Growth (3Y) | 241.93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5.74% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 88.04M | Net Income (TTM) | -784.96M |
| ROE | N/A | ROA | -55.10% |
| Gross Margin | 88.50% | Operating Margin | -695.44% |
| Net Margin | -891.60% | Free Cash Flow (TTM) | -534.82M |
| ROIC | -73.52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.53 |
| Interest Coverage | -5.89 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.56 | P/B Ratio | N/A |
| P/S Ratio | 85.27 | PEG Ratio | -0.40 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 7.51B | Enterprise Value | 7.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 88.04M | 18.47M | 7.53M | 94.59M | 70.43M |
| Net Income | -784.96M | -589.53M | -526.24M | -388.96M | -215.31M |
| EPS (Diluted) | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| Gross Profit | 77.91M | -320.93M | -322.59M | -146.23M | -89.51M |
| Operating Income | -612.26M | -536.25M | -496.21M | -324.20M | -186.31M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.42B | 1.40B | 824.32M | 1.01B | 841.32M |
| Total Liabilities | 2.08B | 1.54B | 1.21B | 1.12B | 597.46M |
| Shareholders' Equity | -659.63M | -135.37M | -386.32M | -107.90M | 243.86M |
| Total Debt | 1.28B | 788.68M | 755.77M | 750.30M | 269.93M |
| Cash & Equivalents | 882.22M | 94.86M | 113.02M | 65.58M | 112.67M |
| Current Assets | 916.98M | 1.11B | 628.05M | 795.19M | 535.67M |
| Current Liabilities | 202.45M | 179.67M | 102.68M | 84.62M | 71.86M |